Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Development and validation of a method for the quantitative determination of succinate in rat blood plasma by HPLC-MS/MS

Дата публикации: 16-10-2026 07:41:51

Relevance. Succinate is a central metabolite of the Krebs cycle and also a regulator of numerous processes via the specific succinate receptor SUCNR1. Succinate is an important component of several pharmacological preparations. However, its pharmacokinetics following the administration of these substances remain poorly understood. A sensitive analytical method is required to perform such studies.Objective. To develop and validate a method for the quantitative determination of succinate in rat blood plasma.Methods. The analysis was performed using HPLC-MS/MS — an Ultimate 3000 TSQ Fortis system and a UCT Selectra C18 column (4.6 mm × 100 mm, 3 µm, 100 Å). The separation temperature was 35 °C, and the flow rate was 0.5 mL/min. A gradient elution mode was used with a mixture of 0.1 % aqueous formic acid and 0.1 % formic acid in methanol. The injection volume was 5 µL. For sample preparation, methanol containing chloramphenicol at a concentration of 10 ng/mL as an internal standard was used. A model matrix was used during validation. For succinate detection, the following mass transitions were used in negative ionization mode: 117 m/z → 98.7 m/z, 117 m/z → 73.1 m/z.Results. The method demonstrated selectivity, sensitivity, accuracy, precision, and linearity in the concentration range of 200–20,000 ng/mL. No carryover or matrix effect was observed. The recovery rate was over 96 %. Succinate was stable under the employed storage conditions.Conclusion. A method for the quantitative determination of succinate in rat blood plasma has been developed and validated. This method can be used to analyze endogenous succinate concentrations and the pharmacokinetics of succinate following the administration of succinate-containing drugs.

Основное содержимое страницы с новостью.

1. de Castro Fonseca M, Aguiar CJ, da Rocha Franco JA, et al. GPR91: expanding the frontiers of Krebs cycle intermediates. Cell Commun Signal. 2016 Jan 12;14:3. doi: 10.1186/s12964-016-0126-1.

2. Tretter L, Patocs A, Chinopoulos C. Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis. Biochim Biophys Acta. 2016 Aug;1857(8):1086-1101. doi: 10.1016/j.bbabio.2016.03.012.

3. Калинин Р.Е., Сучков И.А., Райцев С.Н. и др. Роль фактора, индуцируемого гипоксией, 1α при адаптации к гипоксии в патогенезе новой коронавирусной болезни 2019. Российский медико-биологический вестник имени академика И. П. Павлова. 2024;32(1):133-144. [ doi: 10.17816/PAVLOVJ165536.

4. He W, Miao FJ, Lin DC, et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature. 2004 May 13;429(6988): 188-93. doi: 10.1038/nature02488.

5. Gilissen J, Jouret F, Pirotte B, Hanson J. Insight into SUCNR1 (GPR91) structure and function. Pharmacol Ther. 2016 Mar;159:56-65. doi: 10.1016/j.pharmthera.2016.01.008.

6. Оковитый С.В., Радько С.В., Шустов Е.Б. Сукцинатные рецепторы (SUCNR1) как перспективная мишень фармакотерапии. Химико-фармацевтический журнал. 2015; 49(9):3-7. doi: 10.30906/0023-1134-2015-49-9-3-7.

7. Lamy C, Mansard C, Blondel L, et al. Quantification of succinic acid levels, linked to succinate dehydrogenase (SDH) dysfunctions, by an automated and fully validated liquid chromatography tandem mass spectrometry method suitable for multi-matrix applications. J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Jan 15;1189:123085. doi: 10.1016/j.jchromb.2021.123085.

8. Bao X, Wu J, Shuch B, et al. Quantitative Profiling of Oncometabolites in Frozen and Formalin-Fixed Paraffin-Embedded Tissue Specimens by Liquid Chromatography Coupled with Tandem Mass Spectrometry. Sci Rep. 2019 Aug 2;9(1):11238. doi: 10.1038/s41598-019-47669-5.

9. Jung Y, Song JS, Ahn S. Pharmacokinetics and Tissue Distribution of 13C-Labeled Succinic Acid in Mice. Nutrients. 2022 Nov 10;14(22):4757. doi: 10.3390/nu14224757.

10. Xu L, Zha A, Xiong X, Sun D. Determination of succinic acid and lactic acid in pigs' serum, intestinal contents, and meat by ultrahighperformance liquid chromatography-tandem mass spectrometry. Rapid Commun Mass Spectrom. 2024 Aug 15;38(15):e9769. doi: 10.1002/rcm.9769.

11. Shi Y, Tse S, Rago B, et al. Quantification of fumarate and investigation of endogenous and exogenous fumarate stability in rat plasma by LC-MS/MS. Bioanalysis. 2016 Apr;8(7):661-75. doi: 10.4155/bio-2015-0026.

12. Monostori P, Klinke G, Richter S, et al. Simultaneous determination of 3-hydroxypropionic acid, methylmalonic acid and methylcitric acid in dried blood spots: Second-tier LC-MS/MS assay for newborn screening of propionic acidemia, methylmalonic acidemias and combined remethylation disorders. PLoS One. 2017 Sep 15;12(9):e0184897. doi: 10.1371/journal.pone.0184897.

13. Sadagopan N, Li W, Roberds SL, et al. Circulating succinate is elevated in rodent models of hypertension and metabolic disease. Am J Hypertens. 2007 Nov;20(11):1209-15. doi: 10.1016/j.amjhyper.2007.05.010.

14. Kushnir MM, Komaromy-Hiller G, Shushan B, et al. Analysis of dicarboxylic acids by tandem mass spectrometry. High-throughput quantitative measurement of methylmalonic acid in serum, plasma, and urine. Clin Chem. 2001 Nov;47(11):1993-2002.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Application of gas chromatography coupled with mass spectrometry in bioanalytical research07.6716-10-2026
2Preclinical study of pharmacokinetics and toxicokinetics of innovative peptide drug metilin010.2216-10-2026
3Exploring the use of CyreneTM for the amidation of E3 ligase recruiters: efficient access to PROTAC precursors08.2520-10-2026
4Influence of the ATP-sensitive potassium channel blocker glibenclamide on the nephroprotective effect of polydatin in cisplatin-induced acute kidney injury06.3216-10-2026
5Development of a reporter cell line expressing vascular endothelial growth factor receptor 2 and a firefly luciferase reporter gene based on CHO-K1 cells (CHO-KDR/LUC)08.3816-10-2026
6The Potential Mitigating Effect of Curcumin Root Extract Against Synthetic Anabolic Steroid Boldenone-Induced Kidney Injury in Male Rats [version 2; peer review: 2 approved with reservations]010.8715-07-2026
7Genotoxicity  effects in Cancer Patients: Evaluation by Micronucleus and Comet Assays and Correlation with Biochemical and Hematological Indices [version 2; peer review: 1 approved, 1 approved with reservations]06.8317-07-2026
8Mass spectrometry platform could shrink cancer drug discovery cycle to four hours7820-06-2026
9Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology017.5722-10-2026
10Peripheral 5-HT<sub>3A</sub> and DP<sub>2</sub> targets as the basis for the analgesic action of the novel isoquinoline derivative G-10408.716-10-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.31. Источник: www.pharmacokinetica.ru.